Biostar Pharmaceuticals, Inc. — Form D
Biostar Pharmaceuticals, Inc. of Xianyang, Shaanxi, F4, a company, filed a Form D exempt-offering notice with the SEC on 2009-11-25. The offering totals $2.1M, of which $2.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-11-25
- Form: D
- Accession: 0001185185-09-001253
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.1M
- Amount sold: $2.1M
- Investors: 13
- Date of first sale: 2009-11-18
- Security types: equity
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-111544
Issuer
- Name: Biostar Pharmaceuticals, Inc.
- CIK: 0001418133
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2007
- Address: No. 588 Shiji Xi Road, Xianyang, Shaanxi, F4, 712046
- Phone: 86-29-33686638
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Qinghua Liu | Director | Xianyang, Shaanxi, F4 |
| Xifeng Nie | Director | Xianyang, Shaanxi, F4 |
| Michael Segal | Director | New York, NY |
| Ronghua Wang | Director | Xianyang, Shaanxi, F4 |
| Haipeng Wu | Director | Xianyang, Shaanxi, F4 |
| Shuang Gong | Executive Officer | Xianyang, Shaanxi, F4 |
| Ronghua Wang | Executive Officer | Xianyang, Shaanxi, F4 |
| Amei Zhang | Executive Officer | Xianyang, Shaanxi, F4 |
| Elaine Zhao | Executive Officer | Diamond Bar, CA |
Other filings by this issuer (1)
More